NAMS Market Cap & Key Metrics
NewAmsterdam Pharma Company N.V.
$20.62
+$0.61(+3.05%)
38
Overall
50
Value
18
Tech
47
Quality
Market Cap
$2.39B
Volume
881.93K
52W Range
$20.91 - $42.21
Target Price
$51.00
NAMS market cap is $2.39B. This page lists NewAmsterdam Pharma Company N.V.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
NAMS Key Metrics
- Market cap
- $2.39B
- EPS estimate, current year
- $-1.82
- EPS growth, 3-year
- -21.46%
- Value score
- 50
- Quality score
- 47
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $22.50M | $45.56M | $14.09M | $102.69M |
| EBITDA | -$205.00M | -$241.71M | -$176.86M | -$22.34M |
| EPS | $-1.72 | $-2.56 | $-2.15 | $-0.96 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $20.62 | +3.0% | 881.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW